tera.ai

Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

All entities

Entity

HARMONi-2 trial overall survival analysis

publication1 mentionslast seen Sep 16, 2026

A randomized, double-blind Phase III trial comparing ivonescimab monotherapy to pembrolizumab monotherapy in patients with PD-L1-positive advanced NSCLC, conducted in China by Akeso.

Relationships 1

HARMONi-2 trial overall survival analysis

Relationship

HARMONi-2 trial overall survival analysiscitesivonescimab

90% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1